Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Dementia 1 Alzheimer Disease 1

Interventions

Cyclophosphamide 26 Rituximab 17 Etoposide 16 Methotrexate 15 Dexamethasone 15 Cytarabine 15 Vincristine 14 Prednisone 11 Doxorubicin 11 Radiotherapy 10 blinatumomab 8 fludarabine 7 Mercaptopurine 7 Filgrastim 7 Daunorubicin 7 Asparaginase 7 pegaspargase 6 Granulocyte Colony-Stimulating Factor 6 Methylprednisolone 5 Drug Therapy 5 Dasatinib 5 venetoclax 4 prednylidene 4 etoposide phosphate 4 deltacortene 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Magnetic Resonance Spectroscopy 4 Gemcitabine 4 Busulfan 4 Bendamustine Hydrochloride 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × UE2343 × Lymphoid × Clear all

NCT06125951 2026-04-23

XanaMIA

Actinogen Medical

Phase 2/3 Active not recruiting

Alzheimer Disease, Dementia, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡